COVID-19 vaccination in India

Last updated

COVID-19 vaccination programme
India Total Doses Administered by State.png
Per capita fully vaccination map as of 1 Nov 2021 [lower-alpha 1] [1]
Date16 January 2021 (2021-01-16) – present
(304 days ago)
Location Flag of India.svg India
Cause COVID-19 pandemic
TargetImmunisation of Indians against COVID-19
Budget35,000 crore (US$4.6 billion) [2]
Organised by Government of India
Indian Council of Medical Research
State governments of India
  • 54% of the Indian population has received one dose.
  • 27% of the Indian population has received both doses
Website ,

India began administration of COVID-19 vaccines on 16 January 2021. As of 15 November 2021, India has administered over 1.13 billion doses overall, including first and second doses of the currently-approved vaccines. [3] [4] [5] In India, nearly half the eligible population received at least one shot, and 19 per cent received both the doses in the first nine months after vaccine rollout. [6]


India initially approved the Oxford–AstraZeneca vaccine (manufactured under license by Serum Institute of India under the trade name Covishield) and Covaxin (a vaccine developed locally by Bharat Biotech). They have since been joined by the Sputnik V (manufactured under license by Dr. Reddy's Laboratories, with additional production from Serum Institute of India being started in September [7] [8] ), Moderna vaccines, Johnson & Johnson vaccine and ZyCoV-D (a vaccine locally developed by Zydus Cadila) [lower-alpha 2] [lower-alpha 3] and other vaccine candidates undergoing local clinical trials.

Vaccination programme

Graph of cumulative doses administered across the country

  Total vaccination doses administered across the country   vaccinated (1st dose only)   Fully vaccinated [lower-alpha 4]

Graph of daily doses administered across the country

   Daily vaccinations (1st dose only)   Daily vaccinations (2nd dose only) [3] [9]

Vaccine administration by Gender

Vaccinations in India by gender as of November 16, 2021 (in millions) [10] [11]

Vaccine administration by vaccine brand

Vaccines distributed listed in millionas of 15 November 2021 (23:30 IST) [10] [11]

Vaccine administration by age group

Vaccination by age group as of 15 November 2021 [10] [11]
Age groupPopulation

States by Vaccine Coverage

Note icon.svg (as of 15 September (7:00 IST))

Number of Vaccination Centres

Sites conducting vaccination in India
Emojione BW 1F3E5.svg Vaccine - The Noun Project.svg

Government [fn 1] — 88,936
Private [fn 2] — 2,674

Source: CoWin Dashboard [12]

Note icon.svg As of 22 October (12:00 IST)
OOjs UI icon alert-warning.svg This data is subject to change anytime.

Citizens above the age of 18 can book appointments through the COWIN platform or can do a Walk-In registration on site. All vaccine centres have registration desks, vaccine booths and observation rooms. Vaccine certificates can be downloaded digitally through the COWIN platform, or citizens can ask for a hard copy from vaccination centres. All government run vaccination centers provide free of cost vaccines, private centers do charge. [13]

Background and timeline

A vaccination centre in Delhi. COVID-19 vaccination in Delhi IMG 20210409 100923.jpg
A vaccination centre in Delhi.
India's COVID-19 vaccination deployment till 3 June India's COVID19 vaccination deployment till 3 June 2021.png
India's COVID-19 vaccination deployment till 3 June

First Phase, initial approvals, launch of vaccination programme

In September 2020, India's Health minister Harsh Vardhan stated that the country planned to approve and begin distribution of a vaccine by the first quarter of 2021. [14] The first recipients were to be 30 million health workers directly dealing with COVID patients. [15]

Covishield (2021) K (cropped).jpg
A vial of Covishield, the Indian-manufactured version of the AstraZeneca vaccine.
Bharat Biotech Covaxin Bangalore BESTpedia.jpg
A vial of Covaxin

On 1 January 2021, the Drug Controller General of India (DCGI) approved emergency use of the Oxford–AstraZeneca vaccine (local trade name "Covishield"). [16] [17] [18] On 2 January, the DCGI also granted an interim emergency use authorisation to BBV152 (trade name "Covaxin"), a domestic vaccine developed by Bharat Biotech in association with the Indian Council of Medical Research and National Institute of Virology. [19] This approval was met with some concern, as the vaccine had not then completed phase 3 clinical trials. [20] Due to this status, those receiving Covaxin were required to sign a consent form, [21] while some states chose to relegate Covaxin to a "buffer stock" and primarily distribute Covishield. [22]

COVID-19 vaccination roll out in AIIMS, New Delhi, India on 16 January 2021 COVID-19 vaccination roll out in AIIMS, New Delhi, India on 16 Jan 2021.jpg
COVID-19 vaccination roll out in AIIMS, New Delhi, India on 16 January 2021

India began its vaccination programme on 16 January 2021, operating 3,006 vaccination centres on the onset. [23] Each vaccination centre will offer either Covishield or Covaxin, but not both. [24] 165,714 people were vaccinated on the first day of availability. Difficulties in uploading beneficiary lists at some sites caused delays. [25] In the first three days, 631,417 people were vaccinated. Of these, 0.18% reported side-effects and nine people (0.002%) were admitted to hospitals for observation and treatment. [26] [27] Within those first days, there were concerns about low turnout, due to a combination of vaccine safety concerns, technical problems with the software used, and misinformation. [28]

The first phase of the rollout involved health workers and frontline workers, including police, paramilitary forces, sanitation workers, and disaster management volunteers. [23] By 1 March, only 14 million healthcare and frontline workers had been vaccinated, falling short of the original goal of 30 million. [29]

Second phase

The next phase of the vaccine rollout covered all residents over the age of 60, residents between the ages of 45 and 60 with one or more qualifying comorbidities, and any health care or frontline worker that did not receive a dose during phase 1. Online registration began on 1 March via the Aarogya Setu app and Co-WIN ("Winning over COVID-19") website. [30] [31] [32] Amid the beginnings of a major second wave of infections in the country, [33] [34] [35] vaccine exports were suspended in March 2021, and the government ordered 110 million Covishield doses from SII. [36] The company aims to produce 100 million doses per month, but by May 2021 its production capacity was only 60–70 million doses. [37] [38] Following the conclusion of its trial, the DCGI issued a standard emergency use authorisation to Covaxin on 11 March 2021. [39]

From 1 April, eligibility was extended to all residents over the age of 45. [40] On 8 April, Prime Minister Narendra Modi called for a four-day Teeka Utsav ("Vaccine Festival") from 11 to 14 April, with a goal to increase the pace of the program by vaccinating as many eligible residents as possible. By the end of the Utsav, India had reached a total of over 111 million vaccine doses to-date. [41] [42] [43]

Third phase, Sputnik V approval

On 12 April, the DCGI approved Russia's Sputnik V vaccine for emergency use in India. A phase 3 trial was conducted in the country in September 2020, which showed 91.6% efficacy. [44] The local distributor Dr. Reddy's Laboratories stated that it planned to have the vaccine in India by late May 2021. [45]

On 19 April, it was announced that the next phase of the vaccination programme would begin on 1 May, extending eligibility to all residents over the age of 18. Under phase 3, individual stakeholders were also given more flexibility in how they conduct the vaccination programme. As part of this plan, only half of the vaccines procured by the Central Drugs Laboratory from manufacturers would be distributed by the central government. This supply would go to government-run clinics and be offered free-of-charge to residents 45 and over and priority workers and siphoned off to states based on factors such as the number of active cases and how quickly they are administering vaccines. The remainder would be offered to individual states and purchased on the open market (including private hospitals), which would be able to serve residents over the age of 18. [46] [47] [48]

Registration for the next phase began on 28 April; a single-day record of nearly 13.3 million people registered. [49] Due to supply issues, several states, including Delhi, Gujarat and Madhya Pradesh announced that they would delay their wider rollouts of vaccines to later in the month. [50]

The initial shipment of 150,000 Sputnik V doses arrived on 1 May, and began to be administered on 14 May. [51] [52] [53] An estimated 156 million doses is expected between August and December; initially, doses will be sourced from Russia, but domestic production is expected to begin by August 2021. [54] [55] [56]

On 13 May, the DCGI approved phase 2 and phase 3 trials of Covaxin on children 2–18. [57] On 14 May, health officials projected that based on the anticipated approval of additional vaccine options, it could receive at least 2.17 billion more vaccine doses from August to December 2021. [58] [59] On 25 May, India exceeded 200 million vaccine doses administered in total. [60] On 3 June, the Ministry of Health and Family Welfare pre-ordered 300 million doses of a potential fourth vaccine, Corbevax, which is undergoing phase 3 clinical trials. [61]

On 23 May, the union government allowed walk-in registrations for vaccination throughout the country; a health worker at the vaccination centre would register the recipient in the Co-win vaccination database. The government claimed in an affidavit to the Supreme Court that as of June 23 about 78 per cent of vaccines had been administered via walk-in registration. [62]

Return to centralised procurement

On 31 May, an affidavit was issued in the Supreme Court of India requesting a review of the central government's vaccine distribution strategy, suggesting that the decision to only offer doses at no charge to priority workers and residents over the age of 45 was "prima facie arbitrary and irrational". [63]

On 7 June, Prime Minister Modi announced that India would migrate back to centralised procurement of vaccines by 21 June. In an address, Modi stated that multiple chief ministers had requested that the central government reconsider its new distribution strategy and reinstate the system it had used before May. As before, the centre will procure up to 75% of the country's vaccine supplies from manufacturers in bulk and distribute them to states at no additional charge. Vaccines would now be offered at no charge for those in the 18–44 age group. Private hospitals will still be responsible for the remaining 25% of procurement, but fees for appointments are now capped at 150 (US$2.00). [64] [65]

On 21 June, the day these changes took effect, approximately 8,270,000 doses were administered—India's largest single-day total till that point. The states of Madhya Pradesh and Karnataka had the highest local totals. [66] [67] [68] Member of Parliament, Rajya Sabha P. Chidambaram accused Bharatiya Janata Party of having "hoarded" vaccine doses in the days leading up to 21 June in order to encourage larger numbers; seven states controlled by the BJP were among the top ten states to have administered vaccine doses that day, few of these states had below-average vaccination numbers in the days leading up to 21 June (such as Madhya Pradesh, which went from 692 doses on 20 June to 1,690,000 the next day, and numbers had dropped significantly in the state the next day). [69] [70] [71] [72]

On 23 June, India surpassed over 300 million vaccine doses administered in total. [73] On 28 June, India overtook the United States in total vaccine doses administered. [74] On 29 June, the DCGI approved the Moderna vaccine (which is being imported by Cipla) for emergency use. Vinod Kumar Paul stated that the Pfizer vaccine was also likely to be approved soon. [75] [76]

500 million mark, Johnson & Johnson Covid-19 vaccine approval and record

On 6 August 2021, India crossed the 500 million doses milestone within 6 months from the onset of the vaccination program. [77]

On 7 August 2021, the Drug Controller General of India (DCGI) approved emergency use of the Johnson and Johnson single-dose vaccine. [78] On 16 Aug 2021, India administered around 8.81 million doses of COVID-19 vaccines, achieving the highest single-day record and overtaking its own previous record of 8.61 million doses, by 16 August the cumulative doses had surpassed the 55 millon mark. [79] [80]

ZyCoV-D approval for ages 12 & above and single day vaccination records

On 20 August 2021, India granted emergency use approval to the world's first DNA based COVID-19 vaccine, ZyCoV-D manufactured by Zydus Cadila for adults and children aged 12 years and above. The vaccine is administered using a needle-free applicator. [81] [82] The government announced on 30 September 2021 that the ZyCoV-D vaccine will be a three dose vaccine and it will be included in the Covid vaccination programme of India. [83]

Since August 10, 2021, foreign nationals residing in India can now receive the COVID-19 vaccine by registering themselves on the Cowin platform; like other eligible beneficiaries, the foreign nationals can book a slot via the portal and use their passport as a document to verify their identity for the registration process. [84]

By 26 August 2021, 50% of the adult population in India were inoculated with at least one dose of the approved vaccines, which included 99% coverage among healthcare workers and 100% front-line workers for the first dose. [85]

On 27 August 2021, India crossed the milestone of administering more than 10 million (1 crore) doses of COVID-19 vaccine in a single day, setting a new world record. Uttar Pradesh topped the list with 2.8 million doses, followed by Karnataka with 1 million doses and Maharashtra at third with 0.98 million doses. [86]

On 29 August 2021, Himachal Pradesh became the first state to complete administering first doses of COVID-19 vaccines to 100% of the population. [87] On 31 August, India again set another single-day vaccination record by inoculating around 12 million (1.2 Crore) doses in 24 hours. [88]

By September 2021, all adult people in Sikkim, Dadra and Nagar Haveli, Himachal Pradesh, Goa, Ladakh, and Lakshadweep have received at least one dose of Covid vaccine as the cumulative jabs administered in the country crossed 75 crores. Many city corporations, talukas, gram panchayats and districts had also administered the first dose of COVID-19 vaccination to 100 per cent of their adult population. [89] [90] [91]

As many as 25 million people were vaccinated on Narendra Modi's birthday on the 17th of September 2021. This is the highest single-day vaccination tally so far in the whole world. [92] There are allegations that a lot of pressure could have been put on officials to increase and twist to record vaccination numbers on the Prime Minister's birthday as some people who had not received their Covid shots somehow seem to have been issued vaccination certificates including those who are deceased. [93] [94]

On 27 September, India administered over 1 crore vaccine doses for the fifth time, and total vaccination coverage crossed 86 crore (860 million). [95]

On 2 October, Union health minister Mansukh Mandaviya announced that India crossed the landmark of administrating 90 crore vaccine doses. [96]

1 billion mark, vaccine clinical trial for children aged 7-11 and government's view on booster shots

The Government and India's drug regulator allowed vaccine manufacturer, Serum Institute on 28 September 2021 to enroll children between seven and 11 years of age for its COVID-19 vaccine trial. [97]

The conversation around the booster doses of COVID-19 vaccines gained momentum after people in many western countries were inoculated with the booster dose, or the third dose. The debate is raging in India where a major chunk of the eligible population has already been inoculated with at least one dose since the beginning of the Covid vaccination drive in January. The Indian government has, by far, maintained that booster shots of Covid vaccines and the benefit they provide are under purview and study, the current focus should be on ensuring two doses for every adult in the country. [98]

On 21 October 2021, India crossed the one billion mark for administered doses. [99]

Vaccine development and distribution

Prime Minister Narendra Modi visiting the Serum Institute of India on 28 November 2020. The Prime Minister, Shri Narendra Modi visits the Serum Institute of India, in Pune on November 28, 2020 (4).jpg
Prime Minister Narendra Modi visiting the Serum Institute of India on 28 November 2020.

As of early May 2020, there were over 30 vaccine candidates in development in India, many of which were already in pre-clinical trials. [100]

The Pune-based Serum Institute of India (SII) is the world's largest vaccine maker. This existing capacity enabled India to be a major participant in the COVAX programme to distribute vaccines to developing countries. [101] In February 2020, SII had begun animal trials of vaccine candidates. [102] SII announced in April 2020 that it would apply for clinical trials from the Drug Controller General of India (DCGI) in April 2020. SII president Adar Poonawalla said that a vaccine would be delivered within a year, but projected an efficacy between 70 and 80%. [103]

In August 2020, SII received approvals for phase 2 and phase 3 trials of its version of a vaccine being developed by AstraZeneca and the University of Oxford's Vaccitech. [104] SII joined GAVI in a partnership with the Bill & Melinda Gates Foundation to produce 100 million doses of vaccine for developing countries. [105] The SII planned to manufacture 1.5 and 2.5 billion doses of the AstraZeneca vaccine per-year under the trade name "Covishield". [106] By its approval in January 2021, the company had stockpiled 50 million doses, but well short of its own target of 400 million. [107] [108] The government ordered 21 million doses to be delivered by February, but the company said no indication of any further orders were given. [36] The company began to export the remaining stocks instead. [106]

Hyderabad-based Bharat Biotech, in collaboration with U.S.-based FluGen, expected to begin the first clinical trials of a nasal vaccine by late-2020. [109] The Indian Council of Medical Research partnered with Bharat Biotech in May 2020 to develop a COVID vaccine entirely within India. [110] In June 2020, it received DCGI approval to begin phase 1 and phase 2 trials on its vaccine, BBV152 (trade name "Covaxin"). [111] In September 2020, it was reported that in pre-clinical trials on animals, Covaxin was able to build immunity. [112] In July 2021, Bharat Biotech reported the vaccine to be 64% (95% CI, 2982%) effective against asymptomatic cases, 78% (6586%) effective against symptomatic cases, 93% (57100%) effective against severe COVID-19 infection, and 65% (3383%) effective against the Delta variant. [113] [114] On 20 April 2021, Bharat Biotech announced that it had expanded its production capabilities for Covaxin to 700 million doses per-year. [115]

Cadila Healthcare began vaccine development in March 2020, including a viral vector vaccine and a DNA plasmid vaccine. [116] [117] In mid-July 2020, Cadila held early human trials of its vaccine candidate ZyCoV-D, [118] and received approval for phase 3 trials in January 2021. [119] [120] It began large-scale production in April 2021, with Cadila expecting to receive emergency authorisation between May and June 2021. [121] On 1 July 2021, Cadila Healthcare reported the efficacy to be 66.6% against symptomatic COVID-19 and 100% against moderate or severe disease in its interim analysis of its phase 3 trial data. [122] [123]

In September 2020, Dr. Reddy's partnered with the Russian Direct Investment Fund (RDIF) to conduct phase 3 trials of the Sputnik V vaccine in India, and to distribute the vaccine there once approved. [124] [125] In April 2021, RDIF CEO Kirill Dmitriev told NDTV that they had "five great manufacturers in India" who would be producing the vaccine, and felt that the country could become Sputnik V's "production hub" for use and export. [126] Dr. Reddy's is also working with the RDIF on approval of "Sputnik Light"—a regiment of Sputnik V consisting only of the first dose. [56]

In April 2021, phase 3 clinical trials were approved for another vaccine, Corbevax, a protein subunit that is being developed by BioE, the Baylor College of Medicine, and Dynavax Technologies. [61] [127]

On 2 June 2021, the DCGI removed the requirement that India-specific clinical trials (bridging trials) be held for vaccine candidates developed outside of India, provided that they are already approved by a recognised international public health agency such as the World Health Organization (WHO), European Medicines Agency (EMA), US Food and Drug Administration (FDA), UK Medicines and Healthcare products Regulatory Agency (MHRA), or Japan's Pharmaceuticals and Medical Devices Agency. These changes were intended to help expedite the availability of vaccines already in use in other countries. [75] [128]

In mid-July, it was reported that approval of the Moderna and Pfizer vaccines, as well as a shipment of vaccines donated by the United States (which includes the AstraZeneca, Janssen, Moderna, and Pfizer vaccines), had faced delays due to requests from their manufacturers for indemnity clauses from Indian authorities, which would relieve them from legal liability for adverse reactions. [129] [130]

On 21 September 2021, the Indian Government said that it will not purchase the Pfizer-BioNTech and Moderna vaccines as domestic output of more affordable and easier-to-store vaccines has jumped. [131]

In the Quad summit, Prime Minister Narendra Modi announced that India would make 8 million doses of J&J vaccine available by the end of October under the Quad vaccine partnership. It will be manufactured in India by the Biological E. This would be ready by the end of October, compatible with our decision to resume vaccine export. [132]

Vaccine deployment strategies

Optimizing vaccination deployment for India [133] includes tailoring of strategies to the demographic and epidemiologic situation by modeling vaccination scenarios, [134] explore measures to reach children at risk [135] and co-optimizing vaccination strategy for societal and individual benefit in parallel. [136]

Global distribution

AstraZeneca (Indian version) 2021 cropped.jpg
A vial of Covishield, the Indian-manufactured version of the AstraZeneca vaccine.
A vial of Covaxin

In January 2021, India began a humanitarian initiative known as Vaccine Maitri (vaccine friendship), which aims to leverage the country's pharmaceutical industry to export Indian-manufactured vaccines to other countries. [137] [138] The Ministry of External Affairs stated that since 20 January, India had donated over 5.5 million vaccines to neighbouring countries such as Bahrain, Bangladesh, Bhutan, Maldives, Mauritius, Myanmar, Nepal, Seychelles, and Sri Lanka, and that the country was also planning to send doses to Africa, Nicaragua, Oman, the Caribbean Community, and the COVAX programme, and to distribute vaccines to other countries via commercial exports. [139] [140]

A spokesperson of the MEA stated that "In line with the Prime Minister's announcement that India sees international cooperation in the fight against the COVID-19 pandemic as its duty, we have played the role of the first responder in our neighbourhood as well as undertaken supplies to countries beyond." [139] [140] In response to these donations, Secretary-General of the United Nations António Guterres stated that he "strongly hope[s] that India will have all the instruments that are necessary to play a major role in making sure that a global vaccination is campaign is made possible", and went on to say that, "I think that the production capacity of India is the best asset that the world has today. I hope the world understands that it must be fully used." [141]

As of 10 March 2021, India had distributed over 58 million vaccine doses to 65 nations through the scheme, [138] but due to India's domestic need for vaccines, these exports were suspended later in March and the suspension was expected to continue throughout 2021. [142]

The Health Minister of India, Mr. Mansukh Mandaviya announced in September that India will resume the export of vaccines from October to the rest of the world. [143]

Vaccine on order

VaccineStatusProduction CapacityPlanned CapacityDoses orderedApprovalDeployment
Covishield Green check.svg In use840 million [144] -750 million [145] [146] Green check.svg 01 January 2021 [147] Green check.svg 16 January 2021 [148]
Covaxin Green check.svg In use700 million [149] -550 million [145] Green check.svg 03 January 2021 [150] Green check.svg 16 January 2021 [148]
Sputnik V Green check.svg In use140 million-156 million [151] [145] Green check.svg 12 April 2021 [44] Green check.svg 14 May 2021 [152]
Moderna Green check.svg ApprovedImport only [153] --Green check.svg 29 June 2021 [154] Dark Red x.svg Order Cancelled [155]
Johnson & Johnson Green check.svg Approved-8 million [132] -Green check.svg 7 Aug 2021 [156] Deliveries expected from October 2021 [132]
ZyCoV-D Green check.svg Approved-240 million [157] 50 million [145] Green check.svg 20 August 2021 [158] Deliveries expected from October 2021
Corbevax Phase III trials-960 million [159] 300 million [160] AwaitingDark Red x.svg Not yet
Covovax Phase III trials--200 million [145] AwaitingDark Red x.svg Not yet

In September 2021, India's government announced that it would not buy COVID-19 shots from Pfizer (PFE.N)/BioNTech (22UAy.DE) and Moderna (MRNA.O), mainly because the domestic output of more affordable and easier-to-store vaccines of Serum Institute of India, Bharat Biotech & Cadila Healthcare has jumped. India will make 8 million doses of the Johnson and Johnson vaccine available by the end of October under the Quad vaccine partnership. [132]

Vaccines in trial stage

VaccineType (technology)Phase IPhase IIPhase IIINo. of Participants in Clinical TrialPlanned Capacity
Corbevax Subunit (using an antigen)Green check.svg CompletedGreen check.svg CompletedIn progress1,628 [162] 960 million [159]
BBV154 Adenovirus vector (intranasal)Green check.svg CompletedIn progressPending175 [163] [164] 100 million [145]
HGC019 mRNAGreen check.svg CompletedIn progressPending120 [165] 60 million [145]

Vaccination rollout statistics by State or UT

State/union territoryPopulation (2011 census)1st dose2nd doseCumulative doses administeredPercentage of people given one dosePercentage of people fully vaccinated
121.06 crores69,26,23,23727,88,15,31697,14,38,553
Andaman and Nicobar Islands 3,80,5812,92,2021,72,2474,64,449
Andhra Pradesh 4,95,77,1032,98,88,4131,64,45,5304,63,33,943
Arunachal Pradesh 13,83,7277,64,9654,81,56412,46,529
Assam 3,12,05,5761,96,97,34265,11,1772,62,08,519
Bihar 10,40,99,4524,72,28,0201,41,68,7286,13,96,748
Chandigarh 10,55,4509,17,1174,98,49214,15,609
Chhattisgarh 2,55,45,1981,37,64,64161,64,7211,99,29,362
Dadra and Nagar Haveli and Daman and Diu 5,86,9566,39,8882,40,9338,80,821
Delhi 1,67,87,9411,15,86,34351,90,5501,67,76,893
Goa 14,58,54512,09,9156,15,83518,25,750
Gujarat 6,04,39,6924,07,42,0811,76,28,6515,83,70,732
Haryana 2,53,51,4621,59,92,93457,96,3792,17,89,313
Himachal Pradesh 68,64,60256,36,53824,75,47381,12,011
Jammu and Kashmir 1,22,67,03274,41,15631,16,4631,05,57,619
Jharkhand 3,29,88,1341,30,49,21737,56,1871,68,05,404
Karnataka 6,10,95,2973,82,71,8001,56,77,2215,39,49,021
Kerala 3,34,06,0612,43,41,2951,03,31,7603,46,73,055
Ladakh 2,74,0002,02,8481,32,0083,34,856
Lakshadweep 64,47354,57639,31593,891
Madhya Pradesh 7,26,26,8094,63,62,9051,35,18,8265,98,81,731
Maharashtra 11,23,74,3335,48,12,5762,21,08,6147,69,21,190
Manipur 25,70,39012,17,4114,34,13216,51,543
Meghalaya 29,66,88910,63,9084,31,97314,95,881
Mizoram 10,97,2066,90,7064,02,47910,93,185
Nagaland 19,78,5026,79,9563,26,31010,06,266
Odisha 4,19,74,2192,12,72,10578,32,8732,91,04,978
Puducherry 12,47,9536,82,8032,77,1359,59,938
Punjab 2,77,43,3381,38,76,48346,32,0921,85,08,575
Rajasthan 6,85,48,4373,95,44,9051,45,12,0935,40,56,998
Sikkim 6,10,5775,16,3183,51,9858,68,303
Tamil Nadu 7,21,47,0303,41,18,72895,80,3984,36,99,126
Telangana 3,50,03,6741,71,85,59764,43,7552,36,29,352
Tripura 36,73,91724,89,25212,71,72137,60,973
Uttar Pradesh 19,98,12,3418,08,85,0971,79,98,1109,88,83,207
Uttarakhand 1,00,86,29272,94,32829,23,7121,02,18,040
West Bengal 9,12,76,1153,84,07,8731,56,35,6245,40,43,497
As of October 14, 2021 7:00 AM IST [166]

As of September 2021, populations above the age of 18 are only eligible for vaccination. The percentage of population inoculated shown in the table above is according to the 2011 Census of India with all age groups. According to the government, based on the projected mid-year count for 2020, the country's total population aged 18 years and above is approximately 94 crore. Around 66% of the 18+ population of the country have received at least one dose of the COVID-19 vaccine since the vaccination drive began. In addition to this, 23% of the eligible population has been fully vaccinated. [167]

Vaccine acceptance in India

Over 80% of the population of India have a positive response for getting anti covid shots. India has one of the lowest vaccine hesitancy in the world. [168] There was vaccine hesitancy in the initial months of 2021, especially in rural India and among poor and tribal populations. Constant government and public awareness drastically reduced vaccine hesitancy. Since May 2021, more than half of daily doses administered in India have been from rural parts. [169] Vaccine centers in India have witnessed large number of people willing to get covid vaccine resulting in overcrowding and mismanagement. Many centers across India in months of April & May reported severe shortage of covid vaccines due to large crowds turning up for vaccination. In cities like Mumbai, New Delhi, Bengaluru many people even after waiting for hours did not receive their covid vaccine due to shortage. [170] Since July, vaccine supply has drastically increased thus India is vaccinating at a very fast pace. [171]

One study published on vaccine acceptance shows that 79.5% of people from Delhi, a union territory in Northern India, want to take a COVID-19 vaccine. [172] In another study which was published from West Bengal, a state in Eastern India, has shown that 77.27% of people want to take the COVID-19 vaccine. [173] According to the finding from these two studies, it can be expected that over 75% of people want to get a COVID-19 vaccine.

Vaccination by state

Arunachal Pradesh

As of July 2021, Arunachal Pradesh Government aims to inoculate 100 per cent of the state's population against COVID-19 by mid-August, chief minister Pema Khandu said. Due to hilly terrain, healthcare workers trekked mountains to administer doses to the rural population living in hills.As many as 7,91,371 doses of COVID-19 vaccines have been administered in Arunachal Pradesh so far, including 6,42,785 first doses and 1,48,586 second doses, according to the Union Health Ministry. [174]

Andhra Pradesh

Andhra Pradesh had received 370,000 doses of Covishield and 20,000 of Covaxin. It was decided that only Covishield would be administered. The state aims to vaccinate 32,000 people a day. However, on the first two days, only 61 and 47.8 per cent of those days' targets could be vaccinated. There were two cases of adverse events, but neither required hospitalization. [175] 7 out 13 districts in the state have administered more than 1 lakh doses. [176]

Note icon.svg As of 19 September

Sites conducting vaccination in AP
Emojione 1F3E5.svg Vaccine - The Noun Project.svg

Total- 2,533
Government- 2,486
Private- 47

Source: CoWin Dashboard


Assam Chief Minister Himanta Biswa Sarma said the state has now become a Covid vaccine surplus state since it has administered vaccines to 5 lakh more people, against the total allocation by the centre. "Till August 19, the state has administered 1,51,73,826 doses of COVID-19 vaccines and out of these, the state has administered 1,21,59,162 doses of vaccines in the last 99 days. On average, the state has administered around 1.3lakh doses per day," Himanta Biswa Sarma said.Further the he has asked to keep a 24x7 vaccination system in some places in the state for the benefit of the people. [177] On the 9th month of the vaccination drive, Assam achieved a milestone of 2 crore vaccines administered in a single day. [178]


Bihar received 569,000 doses of the vaccine. 4,64,160 health workers had registered for the vaccine, and the state expects to vaccinate 30,000 people a day across 300 sites. Some doctors had doubts about the efficacy of Covaxin and refused to take it. [179]


Chhattisgarh government began vaccinations in the 18-44 age category, a mammoth effort given the sheer size of this age group and the national shortages in vaccine supply. The state government has also explained its decision to do away with slot booking for vaccinations (it currently conducts only walk-in operations) as a result of the fact that the poorest of the poor do not have good access to cellphones or the internet and therefore cannot use the Cowin app or website easily. Raigarh district of the state is different. An action plan enabled it to accomplish 100% first-dose vaccination of all eligible adults through meticulous planning and monitoring by field staff.


Union Minister for Health & Family Welfare, Harsh Vardhan at a hospital in Shahdara, reviewing preparations for the vaccine program. The Union Minister for Health & Family Welfare, Science & Technology and Earth Sciences, Dr. Harsh Vardhan visiting the GTB Hospital, Shahdara to review the preparedness of Dry Run of COVID-19 vaccine, in Delhi on January 02, 2021 (2).jpg
Union Minister for Health & Family Welfare, Harsh Vardhan at a hospital in Shahdara, reviewing preparations for the vaccine program.
Health care workers administering the COVID-19 vaccination in New Delhi on 16 January 2021 Health care workers administering covid-19 vaccination in New Delhi on 16 January 2021.jpg
Health care workers administering the COVID-19 vaccination in New Delhi on 16 January 2021

4,319 health workers were administered the vaccine on the first day, and there were 51 minor and one major cases of adverse effects. [180] By day three, four people had been admitted to hospitals following complications, of which three had been later discharged. [26] The cumulative number of COVID-19 vaccine doses administered in the national capital so far is 1,37,85,457, including 39,41,416 second jabs. [181]


As of 24 September 2021 Goa has completely vaccinated 50% of its population .It had completed 100% coverage of first dose to all its eligible population on 10 September. [182]

Himachal Pradesh

Himachal Pradesh has become the first state to vaccinate all its adult population by at least one dose on 1 Sept 2021 [183]


Karnataka Health Minister K. Sudhakar announced on 9 January that the state would be given 13.9 lakh (1.39 million) doses of Covishield in two batches. 6.3 lakh (630,000) health workers had registered for the vaccine. [184] Two people were admitted to hospital following complications; one person was later discharged. [26] [185] The Health Minister has also set an target to completely vaccinate all adults by November end [186]

On 31 July, Karnataka became the first state in South India to cross the 3 crore doses mark [187] and in Bangalore, around 85% of the eligible population has been vaccinated with at least one shot, making the city the second highest after New Delhi. [188]

On 17 September Karnataka completed administering 5 crore doses along with administering around 30 lakh in a single day which is highest for any state [189]


Kerala initially received 433,500 doses of Covishield, and an additional batch of 360,500 Covishield doses was announced three days later. In total, 459,853 people from the state registered for the vaccine, including 1,75,673 healthcare workers from state-run hospitals, 199,937 from private hospitals, 2,932 from federal hospitals, 74,711 police staff and 6,600 municipal workers. A total of 24,558 healthcare workers were vaccinated on the first three days. No adverse reactions were reported. [190] After vaccinating 3.75 lakh health workers by 11 February, the focus of the campaign shifted to other front-line staff such as police and municipal workers. The second dose was provided from 15 February onwards. [191]

See or edit raw graph data.

In order to create public confidence in the vaccine, several prominent officials and politicians took the vaccine. This includes Health Minister KK Shailaja, [192] Chief Minister Pinarayi Vijayan, [193] state police chief Lokanath Behera, [194] former Chief Minister VS Achuthanandan [195] and Thiruvananthapuram District Collector Navajoth Khosa. [194] By 21 February, 3,36,327 health workers and 57,658 other frontline staff had been vaccinated, and Kerala requested more vaccines from the national pool. [196]

Vaccination of senior citizens and people over 45 with pre-existing conditions began in March. In addition, vaccines are also provided to government employees involved in running the upcoming state elections. Since the online registration system was not accessible to everyone, particularly to senior citizens, vaccination was also provided without prior registration. Asha workers would help senior citizens in finding and booking slots at the nearest vaccination centre. District and Taluk hospitals and Primary Health Centres would provide vaccinations, in addition to selected private hospitals and special vaccination camps. [197]

Kerala was affected by the nationwide shortage of vaccines in mid-April, with stocks falling to 7.22 lakh doses. For example, in the Palakkad district, nearly half the camps were not in operational condition due to vaccine shortage. Vaccination centres were directed to use the remaining stocks to vaccinate front-line workers. [198] Vaccination of people in the 18-44 age group with certain medical conditions began in early May, and that of all people in the 40-44 age group began on June 4. These would be provided in public hospitals. [199]

By 16 Aug 2021, half of Kerala's estimated population of 35.4 million (and 61.98% of those over 18) had been vaccinated at least once. [200] By this point, 17,788,931 people had been vaccinated over a period of 213 days. In addition, 19% of the total population had been fully vaccinated.


On 11 July, it was reported that Ladakh had become the first union territory of India to have given the first dose to all of its eligible residents and "guest population" (hotel staff, migrant workers, and Nepalese citizens living in the territory). [201]

Madhya Pradesh

As of June 2, 2021. Madhya Pradesh vaccination has administered more than one crore vaccine doses. The pace of immunization has picked up, and more than 2.0 lakh doses are being administered daily. [202]

Due to a shortage of vaccines, the Madhya Pradesh health department has raised a tender estimated at Rs 50.0 Crores which will be open for bidding from 8 June to 22 June 2021. [203] Other States such as Karnataka have launched similar efforts which have garnered little success. In Cities, the government is making efforts to vaccinate the population by using drive-in vaccination centres. [204] Some government departments are pushing their own employees by bringing in policies such as No Vaccine, No Pay. [205]

In Rural Madhya Pradesh, Immunisation efforts have been marred by rumours and resistance by locals. [206] [207]


COVID-19 vaccination queue on May 1st 2021 in Nagpur COVID-19 vaccination queue 01052021.jpg
COVID-19 vaccination queue on May 1st 2021 in Nagpur

Maharashtra received 963,000 doses of Covishield and 20,000 doses of Covaxin. 785,000 health workers had registered to get the vaccination. 14,883 health workers in Maharashtra given COVID-19 vaccine on Tuesday [208] In Mumbai, only 1,926 people could be vaccinated on the first day due to a combination of low turnout and technical problems with the software. The vaccination drive was temporarily suspended due to the technical glitches in the software alerting people to their vaccination appointments. [28] As of September 2021, Maharashtra has administered 7,69,21,190 doses. [209]


Odisha had received doses of both Covishield and Covaxin. The first vaccine dose was given to a sanitation worker on 16 January. [210] Covishield is the predominant vaccine used in Odisha. All the districts use Covishield to vaccinate their people. The only exception being Khurda where both covaxin and covishield are used to vaccinate people. [211]


DistrictPartilly vaccinatedFully vaccinated
Amritsar 9,28,0682,84,155
Barnala 2,37,96662,623
Bathinda 4,79,5901,32,592
Faridkot 2,64,43685,861
Fatehgarh Sahib 2,79,41071,600
Fazilka 3,27,95374,740
Ferozepur 3,37,67077,565
Gurdaspur 7,14,3272,73,620
Hoshiarpur 9,04,0103,58,254
Jalandhar 11,88,7714,45,477
Kapurthala 3,62,3681,20,103
Ludhiana 17,41,8515,86,147
Mansa 2,58,33454,240
Moga 3,92,51499,182
Pathankot 3,85,5321,40,325
Patiala 8,33,5792,72,205
Rupnagar 3,28,67899,171
Mohali 7,76,8852,98,188
Sangrur 5,25,4631,34,419
Shahid Bhagat Singh Nagar 3,32,1431,15,504
Sri Muktsar Sahib 3,77,74685,001
Tarn Taran 4,23,73899,621
As of 2021-09-13
Sites conducting vaccination in Punjab
Emojione 1F3E5.svg Vaccine - The Noun Project.svg

Total- 627
Government- 593
Private- 34

Source: CoWin Dashboard

Note icon.svg As of 15 September (13:30 IST)
OOjs UI icon alert-warning.svg This data is subject to change anytime.


On 3 January 2021, the state conducted its first round of dry run for COVID vaccination in 7 districts. [212] On 13 January, Rajasthan received the first consignment of COVID-19 vaccines at Jaipur and Udaipur, which included Bharat Biotech's Covaxin and Serum Institute of India's Covishield. [213] The vaccines were then transported to state and district level storage centres.

On 16 January, as a part of the nationwide vaccination programme, the first vaccine dose was given to selected frontline health workers at 167 sites across the state. [214] In a review meeting held in January 2021 by the state government, the state head of World Health Organization said that Rajasthan is the best state in terms of preparation for COVID vaccination. [215] The second dose of the vaccine started from 15 February. [216]

By April 13, the state had administered 1 crore doses of vaccine. [217] On 14 April, a theft of 320 doses of Covaxin was reported from a government hospital in Jaipur. [218]

Since the central government did not agree to absorb vaccine costs, the state government announced free vaccines for the age group 18-45 from 1 May. [219] [220] But the rollout was limited to 11 districts only due to shortage of vaccines. [221] Since May 10, every district in Rajasthan started opening slots for 18-45 age group. [222]

Uttar Pradesh

Uttar Pradesh was the first state to vaccinate over 20 lakh people. [223] Uttar Pradesh received 11,796,780 doses, it consumed 10,261,718 of them, and has 2,211,000 in the pipeline in April. [224]

As of September 2021, Uttar Pradesh is leading in the vaccination coverage with 9,88,83,207 doses administered in the state. [209]

On 25 September 2021 Uttar pradesh has completed administering 10 crore(100million) doses[ citation needed ]

Note icon.svg As of 22 September

Sites conducting vaccination in UP
Emojione 1F3E5.svg Vaccine - The Noun Project.svg

Total- 4,699
Government [fn 1] - 4,600
Private [fn 2] - 99

Source: CoWin Dashboard

West Bengal

The third phase of vaccination commenced from 5 May 2021. [225] The state government had procured one lakh Covaxin doses and 3.5 lakh Covishield doses on its own for the phase 3 immunization. [226]

Adverse events

Like many other vaccinations, COVID-19 vaccines also have a risk of causing side effects. According to India's Union Ministry of Health and Family Welfare, the most common side-effects include pain or swelling at the injection site, fever, irritability and headaches. [227] The UK Government also lists fatigue, nausea and joint pain as common side-effects of the Oxford vaccine (known as Covishield in India). [228] Medical experts maintain that vaccines used are safe and their benefits outweigh the risks. It is also important to note that adverse cases do not necessarily have a causal relationship with the vaccines. [229]

A total of 617 serious adverse events were reported until March 29. Of these, 180 cases resulted in death. The Immunisation Technical Support Unit at the federal health ministry examined 192,000 case reports, including 12,400 deaths. In more than half of the examined cases of death, the cause of death was found to be acute coronary syndrome. However, the documentation had been completed for only 3,500 cases. [230]

By 7 June, 26,000 adverse events had been reported following immunisation. Of this, 24,901 were minor, 412 were significant and 887 were serious. 488 deaths were also reported, including 301 men and 178 women (details of 9 deaths were not available). Both vaccines had an adverse reaction rate of about 0.01% and a fatality rate of around 0.0001% - 24,703 events and 457 deaths from 210 million Covishield doses, 1,497 events and 20 deaths following 25 million Covaxin doses. Maharashtra reported the most adverse events (4,521), followed by Kerala (4,074), Karnataka (2,650) and West Bengal (1,456). [229] [231]

On 15 June, the government published a review of case reports that had occurred between 5 February and 31 March 2021, focusing on 31 cases and one death from anaphylaxis that were believed to have been attributed to the vaccine, out of nearly 60 million doses administered in the time period. Only three of these cases, and the single death of a 68-year-old patient, were determined to be "vaccine-product related", with the remainder having been classified as coincidental, indeterminate, or unclassifiable. The report stated that "mere reporting of deaths and hospitalisations as serious adverse events does not automatically imply that the events were caused due to vaccines. Only properly conducted investigations and causality assessments can help in understanding if any causal relationship exists between the event and the vaccine." [232] [233] [234]

Related Research Articles

Serum Institute of India (SII) is an Indian biotechnology and biopharmaceuticals company. It is the world's largest manufacturer of vaccines located in the city of Pune, India and was founded by Cyrus Poonawalla in 1966. The company is a subsidiary of the holding company 'Cyrus Poonawalla Group'.

COVID-19 pandemic in India Ongoing COVID-19 viral pandemic in India

The COVID-19 pandemic in India is a part of the worldwide pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2. As of 27 September 2021, according to official figures, India has the second-highest number of confirmed cases in the world with 33,678,786 reported cases of COVID-19 infection and the third-highest number of COVID-19 deaths at 463,852 deaths. However these figures exhibit severe under-reporting.

Bharat Biotech Indian multinational biotechnology company and vaccine manufacturer

Bharat Biotech International Limited (BBIL) is an Indian multinational biotechnology company headquartered in Hyderabad, engaged in the drug discovery, drug development, manufacture of vaccines, bio-therapeutics, pharmaceuticals and health care products.

Sputnik V COVID-19 vaccine Vaccine against COVID-19

Sputnik V or Gam-COVID-Vac is an adenovirus viral vector vaccine for COVID-19 developed by the Gamaleya Research Institute of Epidemiology and Microbiology in Russia. It is the world's first registered combination vector vaccine for the prevention of COVID-19, having been registered on 11 August 2020 by the Russian Ministry of Health.

Sinopharm BIBP COVID-19 vaccine Vaccine against COVID-19

The Sinopharm BIBP COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two inactivated virus COVID-19 vaccines developed by Sinopharm's Beijing Institute of Biological Products. It completed Phase III trials in Argentina, Bahrain, Egypt, Morocco, Pakistan, Peru, and the United Arab Emirates (UAE) with over 60,000 participants. BBIBP-CorV shares similar technology with CoronaVac and Covaxin, other inactivated virus vaccines for COVID-19. Its product name is SARS-CoV-2 Vaccine, not to be confused with the similar product name of CoronaVac.

Covaxin Vaccine against COVID-19

Covaxin is an inactivated virus-based COVID-19 vaccine developed by Bharat Biotech in collaboration with the Indian Council of Medical Research - National Institute of Virology.

The COVID-19 vaccination program in the Philippines is an ongoing mass immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Russia

The COVID-19 vaccination campaign in Russia is an ongoing mass immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. Mass vaccinations began in December 2020, starting with primarily doctors, medical workers and teachers, and in January 2021, this was extended to the entire population.

COVID-19 vaccination in South Africa Plan to immunize against COVID-19 in South Africa

COVID-19 vaccination in South Africa is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

ZyCoV-D Vaccine candidate against COVID-19

ZyCoV-D is a DNA plasmid-based COVID-19 vaccine developed by Indian pharmaceutical company Cadila Healthcare, with support from the Biotechnology Industry Research Assistance Council. It is approved for emergency use in India.

The COVID-19 vaccination in Morocco is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Botswana is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

Vaccine Maitri Vaccination initiative by the Indian government

Vaccine Maitri is a humanitarian initiative undertaken by the Indian government to provide COVID-19 vaccines to countries around the world. The government started providing vaccines from 20 January 2021. As of 9 May 2021, India had delivered around 66.3 million doses of vaccines to 95 countries. Of these, 10.7 million doses were gifted to 47 countries by the Government of India. The remaining 54 million were supplied by the Serum Institute of India under its commercial and COVAX obligations. In late March 2021, the Government of India temporarily froze exports of the Covishield, citing India's own COVID crisis and the domestic need for these vaccines. The Health Minister of India, Mr. Mansukh Mandaviya announced in September that India will resume the export of vaccines from October to the rest of the world.

COVID-19 vaccination in Africa Immunisation programme against COVID-19 in Africa

COVID-19 vaccination programs have begun in many countries and territories in Africa. As of 5 July 2021, vaccination campaigns had started in 51 African countries with 36.5 million people receiving at least one dose.

COVID-19 vaccination in Ghana

COVID-19 vaccination in Ghana began on Monday 1 March 2021 after the country became the first recipient of the Oxford-AstraZeneca COVID-19 vaccine as part of the COVAX initiative. As of 6 June 2021, Ghana has administered 1,230,000 vaccine doses.

COVID-19 vaccination in Nigeria Plan to immunize against COVID-19

COVID-19 vaccination in Nigeria is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. Vaccination began on 5 March 2021. As of 8 October 2021, 5,118,422 people have received their first dose a COVID-19 vaccine, and 2,359,781 people have received their second dose.

COVID-19 vaccination in Bangladesh

Bangladesh began the administration of COVID-19 vaccines on 27 January 2021 while mass vaccination started on 7 February 2021.

COVID-19 vaccination in Nepal Immunisation programme against COVID-19 in Nepal

Nepal began administration of COVID-19 vaccines on 27 January 2021. 1 million Oxford-Astrazeneca vaccines were provided by India as a grant while Nepal brought 2 million doses from Serum Institute of India (SII) and was one of the first to receive COVID-19 vaccines. The delivery of the first 1 million doses arrived on 21 February. In March, India's decision to ban exports of vaccines created uncertainty over whether Nepal would be able to continue its vaccinations. By April, SII had only provided half of the 2 million doses for which Nepal had paid in full. A spokesperson for the Indian Ministry of External Affairs rejected the notion of an export ban and said “We will export vaccines taking into account the domestic demand.” By late July, there was still uncertainty in Nepal over when SII would deliver the vaccines that were purchased, although Prime Minister Narendra Modi said India would "resume the supply of vaccines soon."

CoWIN Indian Government COVID-19 vaccination portal

CoWIN is an Indian government web portal for COVID-19 vaccination registration, owned and operated by India's Ministry of Health and Family Welfare. It displays booking slots of COVID-19 vaccine available in the nearby areas and can be booked on the website.


Footnote references

  1. 1 2 All government run vaccination centers provide free of cost vaccines
  2. 1 2 Vaccination Centres/facilities charge as per dose

Web References

  1. . By George Karabassis. Seelect Fully vaccinated option from drop-down from the top of the map to create the shown map.
  2. "Budget 2021: Two more coronavirus vaccines soon, reveals FM Nirmala Sitharaman". Retrieved 13 March 2021.
  3. 1 2 "Vaccination state wise". Ministry of Health and Family Welfare. Retrieved 28 April 2021.(Ambox important.svgThe data on this site changes daily)
  4. "Vaccination Statistics". 21 March 2021. Retrieved 21 March 2021.
  5. "MoHFW | Home". Retrieved 23 September 2021.
  6. DelhiOctober 11, Dipu Rai New; October 11, 2021UPDATED; Ist, 2021 23:48. "Is vaccination the only way to achieve herd immunity against Covid?". India Today. Retrieved 13 October 2021.CS1 maint: numeric names: authors list (link)
  7. "Serum Institute gets DCGI's nod to manufacture Covid vaccine Sputnik V in India". mint. 4 June 2021.
  8. press release
  9. "Our World in Data - India - Vaccination". GitHub. 24 September 2021.
  10. 1 2 3 "Co-Win Statistics". Retrieved 27 April 2021.(Ambox important.svgThe data on this site changes daily)
  11. 1 2 3 " "CoWin API".(Ambox important.svgChange the date in the URL to get correct data.)
  12. "CoWIN dashboard".
  13. "CoWIN".
  14. "Expect Covid-19 vaccine by early next year, will take first shot if any trust deficit: Vardhan". The Times of India. 13 September 2020. Retrieved 13 September 2020.
  15. Kaul, Rhythma (21 October 2020). "30 Million Frontline Workers To Get Covid-19 Vaccine In Phase 1". Hindustan Times. New Delhi. Retrieved 21 October 2020.
  16. "Coronavirus: India approves vaccines from Bharat Biotech and Oxford/AstraZeneca". BBC News. 3 January 2021. Retrieved 22 April 2021.
  17. Beaumont, Peter (24 March 2021). "Delhi reportedly halts AstraZeneca Covid vaccine exports as cases soar". The Guardian. Retrieved 22 April 2021.
  18. "Why is the EU unhappy with AstraZeneca?". BBC News. 6 April 2021. Retrieved 22 April 2021.
  19. "Expert panel recommends Bharat Biotech's Covaxin for restricted emergency use". News18. 2 January 2021.
  20. Prasad, R (15 January 2020). "Vaccine dilemma — to take or not to take Covaxin". The Hindu. Chennai.
  21. Bindu Shajan Perappadan (16 January 2020). "Covaxin recipients asked to sign consent form on 'clinical trial mode'". The Hindu. New Delhi.
  22. Prasad, R (15 January 2020). "Vaccine dilemma — to take or not to take Covaxin". The Hindu. Chennai.
  23. 1 2 "World's largest vaccination programme begins in India on January 16". The Hindu. 15 January 2021. Retrieved 16 January 2021.
  24. Prasad, R (15 January 2020). "Vaccine dilemma — to take or not to take Covaxin". The Hindu. Chennai. Retrieved 16 January 2020.
  25. "No case of post-vaccination hospitalisation reported so far: Health Ministry". The Hindu. New Delhi. 16 January 2020. Retrieved 16 January 2020.
  26. 1 2 3 "Over six lakh vaccinated so far". The Hindu. New Delhi. 19 January 2020. Retrieved 19 January 2020.
  27. "കോവിഡ് വാക്‌സിനേഷന്‍: പാര്‍ശ്വഫലമുണ്ടായത്‌ 0.18% പേരില്‍, ആശുപത്രിയില്‍ പ്രവേശിപ്പിച്ചത് 0.002% പേരെ". Mathrubhumi. New Delhi. 19 January 2020. Retrieved 19 January 2020.
  28. 1 2 Hannah Ellis-Peterson; Amrit Dhillon (20 January 2020). "Indian hesitancy sets back world's biggest Covid vaccination drive". The Guardian. New Delhi. Retrieved 20 January 2020.
  29. Allana, Alia (15 March 2021). "Opinion | How Do You Vaccinate 1.3 Billion People?". The New York Times. ISSN   0362-4331 . Retrieved 15 March 2021.
  30. "Coronavirus Registration for next phase of vaccination on Co-WIN 2.0 portal to open on March 1". The Hindu. 28 February 2021.
  31. "Citizen Registration and Appointment for Vaccination" (PDF).
  32. "All above 60 years of age, 45-plus with comorbidities can get COVID-19 vaccine from March 1". The Economic Times. Retrieved 27 April 2021.
  33. "Covid-19 vaccination: How is India's inoculation drive going". BBC News. 20 April 2021. Retrieved 22 April 2021.
  34. "India reports new record of 103,558 daily Covid cases, as second wave and new lockdowns hit". CNN. Retrieved 22 April 2021.
  35. Yeung, Jessie; Sud, Vedika (21 April 2021). "India's second Covid wave hits like a 'tsunami' as hospitals buckle under weight". CNN. Retrieved 21 April 2021.
  36. 1 2 India’s vaccine shortage will last months, biggest manufacturer warns, Financial Times, 3 May 2021.
  37. PTI (28 December 2020). "Already produced 40-50 million dosages of Covishield vaccine, says Serum Institute". The Hindu.
  38. India is the home of the world’s biggest producer of Covid vaccines. But it’s facing a major internal shortage, CNBC, 5 May 2021.
  39. Leo, Leroy (11 March 2021). "DCGI removes Covaxin out of 'clinical trial mode'". mint. Retrieved 13 May 2021.
  40. "CoWin Upgrade, 50 lakh Daily Target: What to Expect As India Vaccinates Citizens Above 45". 3 April 2021. Retrieved 27 April 2021.
  41. "PM Modi calls for 'Vaccine Utsav' from April 11–14; Aghadi split over vaccine stock; more". India Today. Retrieved 27 April 2021.
  42. "Tika Utsav: India to inoculate citizens on day 2 of 'vaccination festival' today". Hindustan Times. 12 April 2021. Retrieved 27 April 2021.
  43. "Tika Utsav: India's COVID-19 vaccination coverage exceeds 11 crore mark". The Economic Times. Retrieved 27 April 2021.
  44. 1 2 "Experts clear Russia's Sputnik Covid-19 vaccine for use in India". Hindustan Times. 12 April 2021. Retrieved 15 April 2021.
  45. "EXCLUSIVE India to get Russia's Sputnik V vaccine only by end-May". reuters. 26 April 2021. Retrieved 26 April 2021.
  46. "India announces next phase of Covid-19 vaccination, all above 18 yrs eligible". mint. 19 April 2021. Retrieved 28 May 2021.
  47. Koshy, Jacob. "Vaccines for all above 18 from May 1; States can buy directly". The Hindu. Retrieved 25 April 2021.
  48. "COVID-19 vaccine for all above age of 18 years from May 1; states can buy vaccines directly from manufacturers". Times Now News. 19 April 2021. Retrieved 20 April 2021.
  49. "Around 1.33 Crore Apply For Covid Vaccination: 10 Points". Retrieved 1 May 2021.
  50. Yeung, Jessie; Suri, Manveena. "Every adult in India is now eligible for Covid vaccine shots, but some states say they have none to offer". CNN. Retrieved 1 May 2021.
  51. "Watch: Russia's Sputnik V, 3rd Vaccine For India, Arrives In Hyderabad", NDTV, 1 May 201
  52. Kumar, N. Ravi (1 May 2021), "1.5 lakh doses of Sputnik V land in India", The Hindu
  53. Kumar, N. Ravi (14 May 2021). "Sputnik roll out begins, to cost ₹995 per dose". The Hindu. ISSN   0971-751X . Retrieved 15 May 2021.
  54. "Sputnik V Covid-19 vaccine production in India to start in August". The Times of India. New Delhi. 22 May 2021. Retrieved 25 May 2021.
  55. Bharadwaj, Swati. "Sputnik V manufacturing in India to begin after EUA nod". The Times of India. Retrieved 28 May 2021.
  56. 1 2 "Sputnik launched in Hyderabad at ₹995 a dose". Hindustan Times. 15 May 2021. Retrieved 28 May 2021.
  57. "DCGI approves Covaxin clinical trials for children aged 2-18 years". DNA India. 13 May 2021. Retrieved 13 May 2021.
  58. Dey, Sushmi (14 May 2021). "Government vows vaccine push, says will get 217 crore shots from August to December". Times of India. Archived from the original on 16 May 2021. Retrieved 15 May 2021.
  59. Sensharma, Aalok (14 May 2021). "From Intranasal to Covovax, India pins hopes on 5 more COVID-19 vaccines as 2nd wave wreaks havoc". Jagran. New Delhi. Archived from the original on 16 May 2021. Retrieved 16 May 2021.
  60. "200 million vaccine doses administered in India". Hindustan Times. 26 May 2021. Retrieved 26 May 2021.
  61. 1 2 "Health ministry buys 300 mn doses of Biological-E's Covid vaccine in advance". Hindustan Times. 3 June 2021. Retrieved 4 June 2021.
  62. "No Question Of Anyone Being Left Out Of Covid Vaccination Due To Digital Divide, Centre Tells Court". NDTV. Press Trust of India. 27 June 2021. Retrieved 29 June 2021.
  63. "Supreme Court asks govt for a vaccine roadmap, calls policy for 18-44 to pay 'arbitrary, irrational'". The Indian Express. 3 June 2021. Retrieved 25 June 2021.
  64. "PVT hospitals can charge maximum of ₹150 as service fee for vaccination: PM". 7 June 2021.
  65. "It's centralised procurement of vaccines again, says PM Modi". The Hindu. 7 June 2021. Retrieved 7 June 2021.
  66. "Covid vaccination in India: Record 69 lakh Covid vaccine doses administered on day one of revised guidelines". The Times of India. Retrieved 25 June 2021.
  67. "Day 1 of India's new COVID-19 vaccine policy: Record 82.7L doses administered, 'numbers gladdening', tweets PM". Firstpost. 22 June 2021. Retrieved 25 June 2021.
  68. "How MP Bested Other States in Vaccination: Over 8,000 Centres, Monitoring By CM". 21 June 2021. Retrieved 25 June 2021.
  69. Sharma, Supriya. "How India created a 'world record' for highest number of vaccinations in a single day". Retrieved 25 June 2021.
  70. Sharma, Supriya. "How India engineered its single-day Covid-19 vaccination "record"". Quartz. Retrieved 25 June 2021.
  71. ""Sprinting Ahead": BJP Chief On P Chidambaram's Vaccine Record Criticism". Retrieved 25 June 2021.
  72. "After 'Record' High on Monday, Vaccine Numbers Drastically Drop in Some BJP-Ruled States". The Wire. 23 June 2021. Retrieved 24 June 2021.
  73. Jun 23, ANI /; 2021; Ist, 22:53. "India's cumulative Covid-19 vaccination coverage crosses 30 crore | India News - Times of India". The Times of India. Retrieved 25 June 2021.CS1 maint: numeric names: authors list (link)
  74. "'Remarkable Result': India Zooms Past US in Number of Vaccine Doses Given, Time Taken Lesser by Month". 28 June 2021.
  75. 1 2 "India expands Covid vaccine kitty: Moderna gets regulatory nod; Pfizer approval likely soon". The Times of India. 29 June 2021. Retrieved 29 June 2021.
  76. Livemint (29 June 2021). "Cipla gets nod to import Moderna's vaccine for emergency use in India: Report". mint. Retrieved 29 June 2021.
  77. "In 6 months since launch of drive: Vaccine coverage crosses 50 cr doses". INDIAN EXPRESS. 7 August 2021.
  78. "India gets fifth Covid vaccine as Johnson & Johnson's single-shot vaccine gets nod". THE NEW INDIAN EXPRESS. 7 August 2021. Retrieved 7 August 2021.
  79. "At 88 lakh doses, India achieves highest single-day vaccination record". India TV.
  80. "India witnesses highest-ever single-day vaccination of 88.13 doses". The Times of India.
  81. "India gives emergency approval for world's first COVID-19 DNA vaccine". Reuters.
  82. "India approves first Covid vaccine for children above 12 - 5 things to know". Livemint.
  83. "3-dose Zydus vaccine to be included in Covid vaccination programme: Govt". Business Standard India. Press Trust of India. 30 September 2021. Retrieved 30 September 2021.
  84. "Now foreigners can also get Covid-19 vaccine in India: Health ministry". 10 August 2021.
  85. Sushmi Dey (26 August 2021). "Half of India's adults have now got at least one dose of vaccine". The Times of India.
  86. "India administers over 1 cr COVID vaccines in single day, Uttar Pradesh tops chart; PM hails 'momentous feat'". Times Now News.
  87. "Himachal administers first dose of Covid vaccine to 100% of its population". Himdustan Times.
  88. "India administers over 1.2 cr Covid vaccine doses, sets new single-day record". Livemint.
  89. "Covid-19 vaccine: City Beautiful not on Centre's list of 100% first dose coverage".
  90. "Goa achieved 100 pc first dose COVID vaccination, target set to complete 2nd dose by Oct 31: CM Sawant". ANI.
  91. "India administers over 74 crore Covid vaccines; all adults in 6 states, UTs got 1st dose". 12 September 2021.
  92. "India sets record with 2.5 crore COVID-19 jabs in one day". 17 September 2021. Retrieved 18 September 2021.
  93. "A Madhya Pradesh Twist To Record Vaccination Numbers On PM Modi Birthday". Retrieved 23 September 2021.
  94. "Shocking! Woman vaccinated four months after her death due to Covid complications in MP". The New Indian Express. Retrieved 23 September 2021.
  95. "India administers 1 crore vaccine doses for 5th time, vaccination coverage crosses 86 crore".
  96. Oct 2, PTI /; 2021; Ist, 14:34. "Over 90 crore Covid vaccine doses administered in India: Health minister | India News - Times of India". The Times of India. Retrieved 2 October 2021.CS1 maint: numeric names: authors list (link)
  97. Livemint (28 September 2021). "Govt allows Serum Institute to enrol 7-11 year olds in Covid-19 vaccine trial". mint. Retrieved 28 September 2021.
  98. "Do Indians need booster dose of Covid-19 vaccines? Experts answer".
  99. PTI (21 October 2021). "India crosses 100-crore Covid vaccination mark, PM Modi says country 'scripts history'". ThePrint. Retrieved 22 October 2021.
  100. Ray, Meenakshi (6 May 2020). "30 Covid-19 vaccines in different stages of development: Scientists to PM Modi". Hindustan Times. Retrieved 10 May 2020.
  101. Yeung, Jessie; Mitra, Esha (18 April 2021). "The world's biggest vaccine producer is running out of Covid-19 vaccines". CNN. Retrieved 18 April 2021.
  102. Khelkar, Pankaj P. (19 February 2020). "Indian company first to test coronavirus vaccine on animals, human trials expected in 6 months". India Today. Retrieved 13 April 2020.
  103. "Coronavirus vaccine within a year but it won't be 100% effective". The Economic Times. 21 March 2020. Retrieved 22 March 2020.
  104. "Coronavirus vaccine: DCGI gives nod to Serum-Oxford for phase 2, 3 clinical trials in India". Daily News & Analysis . 3 August 2020. Retrieved 4 August 2020.
  105. "Serum Institute to produce up to 100 million Covid-19 vaccine doses for India, other countries". The Times of India. 7 August 2020. Retrieved 10 August 2020.
  106. 1 2 Fletcher, Martin. "Adar Poonawalla: 'Aggression over Covid vaccines is overwhelming . . . Everyone expects to get theirs first'". The Times. ISSN   0140-0460 . Retrieved 28 May 2021.
  107. Schmall, Emily; Yasir, Sameer (3 January 2021). "India Approves Oxford-AstraZeneca Covid-19 Vaccine and 1 Other". The New York Times.
  108. Adar Poonawalla: 'Aggression over jabs is overwhelming Everyone expects to get theirs first, The Times, 1 May 2021. ProQuest   2520110820
  109. "Hyderabad-based biotech firm working on nasal vaccine for Covid-19". India Today. 3 April 2020. Retrieved 6 April 2020.
  110. Chakrabarti, Angana (10 May 2020). "India to develop 'fully indigenous' Covid vaccine as ICMR partners with Bharat Biotech". The Print. Retrieved 11 May 2020.
  111. "India's First COVID-19 Vaccine Candidate Approved for Human Trials". The New York Times. 29 June 2020.
  112. "India's coronavirus vaccine candidate COVAXIN showed positive result in animals: Bharat Biotech". Daily News & Analysis. 12 September 2020. Retrieved 13 September 2020.
  113. Suri M, Hollingsworth J (3 July 2021). "India's homegrown Covid-19 vaccine has 78% efficacy against symptomatic infections, developer says". CNN. Retrieved 3 July 2021.
  114. Ella R, Reddy S, Blackwelder W, Potdar V, Yadav P, Sarangi V, et al. (2 July 2021). "Efficacy, safety, and lot to lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): a double-blind, randomised, controlled phase 3 trial". medRxiv (Preprint). doi:10.1101/2021.06.30.21259439. S2CID   235706046 . Retrieved 3 July 2021.
  115. Bharadwaj, Swati (20 April 2021). "Covid-19: Bharat Biotech ramps up Covaxin capacity to 700 million doses per annum". The Times of India. Retrieved 24 May 2021.
  116. Jayakumar, PB (5 April 2020). "Zydus Cadila, Serum Institute too in the hunt for coronavirus vaccine". India Today. Retrieved 6 April 2020.
  117. "The experiment of coronavirus vaccine on animals started in India, hopefully desired results will come in 4–6 months". Inventia. 8 April 2020. Retrieved 13 April 2020.
  118. "Coronavirus vaccine update: India's second COVID-19 vaccine candidate 'ZyCoV-D' to start human trials; here is all you need to know". The Times of India. 15 July 2020. Retrieved 16 July 2020.
  119. "DBT-BIRAC supported indigenously developed DNA Vaccine Candidate by Zydus Cadila, approved for Phase III clinical trials". Press Information Bureau, Government of India. 3 January 2021. Retrieved 24 May 2021.
  120. "Novel Corona Virus-2019-nCov vaccine by intradermal route in healthy subjects". Clinical Trials Registry - India. Retrieved 10 April 2021.
  121. "Cadila Healthcare starts production of Covid vaccine candidat". livemint. 26 April 2021. Retrieved 26 April 2021.
  122. "Zydus applies to the DCGI for EUA to launch ZyCoV-D, the world's first Plasmid DNA vaccine for COVID-19" (PDF). Cadila Healthcare (Press release). 1 July 2021. Retrieved 1 July 2021.
  123. "Zydus Cadila jab shows 66.6% efficacy, seeks regulatory nod". livemint. 2 July 2021. Retrieved 2 July 2021.
  124. Saxena, Sparshita, ed. (16 September 2020). "Russia's sovereign wealth fund partners with Dr Reddy's for trials and distribution of Sputnik V vaccine in India". Hindustan Times. Retrieved 24 May 2021.
  125. "Russia inks pact to test, supply Sputnik V vaccine to India". The Hindu. 16 September 2020.
  126. "On Sputnik V For India, Price Issues - AstraZeneca Price Too Low, Says Maker". Retrieved 28 May 2021.
  127. "Biological E gets nod to start Phase III trials of COVID-19 vaccine". The Hindu. 24 April 2021.
  128. "Foreign COVID-19 vaccines exempted from local trials, batch testing". Retrieved 29 June 2021.
  129. Sharma, Milan. "Talks with vaccine makers Moderna, Pfizer stuck on indemnity clause: Sources". India Today. Retrieved 20 July 2021.
  130. "Terms of Indemnity for Foreign Makers Hold Up Covid Vaccine Donations from US as Neighbours Get Share". News18. 13 July 2021. Retrieved 20 July 2021.
  131. Arora, Neha; Das, Krishna N.; Ahmed, Aftab (21 September 2021). "India govt won't buy Pfizer, Moderna vaccines amid local output -sources". Reuters.
  132. 1 2 3 4 "India to make available 8 million doses of J&J Covid vaccine: PM Modi at Quad Summit".
  133. Mandal, Sandip; Arinaminpathy, Nimalan; Bhargava, Balram; Panda, Samiran (1 July 2021). "Responsive and agile vaccination strategies against COVID-19 in India". The Lancet Global Health. 9 (9): e1197–e1200. doi:10.1016/S2214-109X(21)00284-9. ISSN   2214-109X. PMC   8248922 . PMID   34217378.
  134. Foy, Brody H.; Wahl, Brian; Mehta, Kayur; Shet, Anita; Menon, Gautam I.; Britto, Carl (1 February 2021). "Comparing COVID-19 vaccine allocation strategies in India: A mathematical modelling study". International Journal of Infectious Diseases. 103: 431–438. doi:10.1016/j.ijid.2020.12.075. ISSN   1201-9712. PMC   7834611 . PMID   33388436.
  135. Gurnani, Vandana; Haldar, Pradeep; Aggarwal, Mahesh Kumar; Das, Manoja Kumar; Chauhan, Ashish; Murray, John; Arora, Narendra Kumar; Jhalani, Manoj; Sudan, Preeti (7 December 2018). "Improving vaccination coverage in India: lessons from Intensified Mission Indradhanush, a cross-sectoral systems strengthening strategy". BMJ. 363: k4782. doi:10.1136/bmj.k4782. ISSN   0959-8138. PMC   6282735 . PMID   30530467.
  136. Hunziker, Patrick (24 July 2021). "Personalized-dose Covid-19 vaccination in a wave of virus Variants of Concern: Trading individual efficacy for societal benefit". Precision Nanomedicine. 4 (3): 805–820. doi: 10.33218/001c.26101 .
  137. Writer (5 March 2021). "Vaccine Maitri: Consignment of covid vaccines airlifted for Guyana, Jamaica". mint. Retrieved 27 April 2021.
  138. 1 2 "Vaccine maitri: 5.8 crore Made-in-India Covid vaccine doses supplied to over 65 nations". India Today. Retrieved 27 April 2021.
  139. 1 2 "India gifted over 55 lakh doses of coronavirus vaccines to several countries: MEA". The Economic Times. Retrieved 27 April 2021.
  140. 1 2 "India gifts over 5.5 mn Covid-19 vaccine doses to several countries: MEA". Business Standard India. Press Trust of India. 28 January 2021. Retrieved 27 April 2021.
  141. "India's vaccine production capacity is best asset world has today, says UN chief". Hindustan Times. 29 January 2021. Retrieved 27 April 2021.
  142. Findlay, Stephanie; Pilling, David (18 May 2021). "Indian vaccine maker extends freeze on export of Covid jabs". Financial Times. Retrieved 19 May 2021.
  143. "Covid vaccine: India to resume vaccine exports from October". BBC News. 21 September 2021. Retrieved 23 September 2021.
  144. Sharma, Manavi Kapur, Niharika. "Adar Poonawalla has confusing—and often contradictory—reasons for India's vaccine shortage". Quartz. Retrieved 10 May 2021.
  145. 1 2 3 4 5 6 7 "Over 2 billion vaccines to be available by Dec: Centre". HindustanTimes. 14 May 2021. Retrieved 29 July 2021.
  146. "Centre pins hopes on 5 Covid vaccines apart from Covishield, Covaxin, Sputnik". Hindustan Times. 14 May 2021. Retrieved 3 June 2021.
  147. "Oxford Covid vaccine approved, three more awaiting nod, confirms Javadekar | India News - Times of India". The Times of India.
  148. 1 2 Perappadan, Bindu Shajan (9 January 2021). "Coronavirus | First phase of vaccination to start on January 16". The Hindu via
  149. "Bharat Biotech ramps up Covaxin production capacity to 700 mn doses per annum". The Hindu. Special Correspondent. 20 April 2021. ISSN   0971-751X . Retrieved 10 May 2021.CS1 maint: others (link)
  150. "India's Wait Over, Drug Regulator Says Covid Vaccines Cleared "110% Safe"".
  151. "Covid 19: India gets third vaccine, Sputnik V". Financial Express. 15 May 2021.
  152. "Dr Reddy's administers first dose of Sputnik V vaccine as part of pilot project". mint. 14 May 2021.
  153. "Government nod for Cipla to import Moderna's COVID-19 vaccine". The Hindu. 29 June 2021.
  154. Kaul, Rhythma (29 June 2021). "Moderna's Covid vaccine approved for use in India". Hindustan Times.
  155. "India to not buy Pfizer, Moderna Covid-19 vaccines as local production jumps: Report". 21 September 2021.
  156. "Johnson & Johnson's Single-Dose Covid Vaccine Approved In India". Retrieved 7 August 2021.
  157. "Cadila Healthcare starts production of Covid vaccine candidate". mint. 24 April 2021. Retrieved 27 April 2021.
  158. "India gives emergency approval for world's first COVID-19 DNA vaccine". Reuters. 20 August 2021.
  159. 1 2 "COVID-19 Vaccines: Biological E to begin producing 75-80 million doses of vaccine candidate from August 2021". Money Control. 7 May 2021. Retrieved 29 July 2021.
  160. Bharadwaj, Swati (3 June 2021). "Bio E to get Rs 1,500 crore advance from government to reserve 30 crore doses of Corbevax". The Times of India. Retrieved 3 June 2021.
  161. "Bio e vaccine candidate gets Ph-III trial nod | India News - Times of India". The Times of India.
  162. Leo L (16 November 2020). "Biological E initiates human trials of vaccine". Mint.
  163. "Bharat Biotech's intranasal vaccine for COVID-19: Everything we know so far about BBV154- Technology News, Firstpost". Tech2. Firstpost. 12 March 2021.
  164. Prabhu, Sunil. "Bharat Biotech's 1st Nasal Covid Vaccine Gets Phase 2/3 Trial Nod". Retrieved 13 August 2021.